Science report shelved for being ‘too pro-EU’
Britain’s £60-billion pharmaceutical and life sciences industry shelved a report calling for the government to pursue a “soft Brexit” strategy after being warned by ministers that it was too pro-EU. Sir Andrew Witty, head of GlaxoSmithKline, and other industry leaders met ministers from the Brexit department this month. They presented the findings of a two-month consultation calling for the preservation of free movement of goods and scientific talent post-Brexit and a “common regulatory framework” for the drugs industry.
Continue Reading http://www.thetimes.co.uk
Join the Discussion